CoChat

Mitochondrion‐Permeable Antioxidants to Treat ROS‐Burst‐Mediated Acute Diseases

Open access
Zhang, Zhong-Wei, Xu, Xiao-Chao, Liu, Ting, Yuan, Shu · 2016 · Oxidative Medicine and Cellular Longevity
Cited by 105

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Reactive oxygen species (ROS) play a crucial role in the inflammatory response and cytokine outbreak, such as during virus infections, diabetes, cancer, cardiovascular diseases, and neurodegenerative diseases. Therefore, antioxidant is an important medicine to ROS‐related diseases. For example, ascorbic acid (vitamin C, VC) was suggested as the candidate antioxidant to treat multiple diseases. However, long‐term use of high‐dose VC causes many side effects. In this review, we compare and analyze all kinds of mitochondrion‐permeable antioxidants, including edaravone, idebenone, α‐Lipoic acid, carotenoids, vitamin E, and coenzyme Q10, and mitochondria‐targeted antioxidants MitoQ and SkQ and propose astaxanthin (a special carotenoid) to be the best antioxidant for ROS‐burst‐mediated acute diseases, like avian influenza infection and ischemia‐reperfusion. Nevertheless, astaxanthins are so unstable that most of them are inactivated after oral administration. Therefore, astaxanthin injection is suggested hypothetically. The drawbacks of the antioxidants are also reviewed, which limit the use of antioxidants as coadjuvants in the treatment of ROS‐associated disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2016/6859523

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 105

Metadata

Authors
Zhang, Z.-W., Xu, X.-C., Liu, T., & Yuan, S.
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2015-11-16
Volume
2016
Issue
1
Pages
6859523-6859523
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W2215956681
Cited by
105
References
16
FWCI
2.90
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.